PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAytu Biopharma
Aytu Biopharma(AYTU)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
AciphexRabeprazole2013-03-26
Gastroesophageal reflux
,
Helicobacter infections
,
Duodenal ulcer
,
Zollinger-ellison syndrome
,
Heartburn
KarbinalCarbinoxamine2013-03-282027-2029
Allergic conjunctivitis
,
Allergic rhinitis perennial
,
Angioedema
,
Vasomotor rhinitis
MetadateMethylphenidate2001-04-032024-2038
Narcolepsy
,
Attention deficit disorder with hyperactivity
,
Depressive disorder
ProstascintCapromab pendetide1996-10-28
—
ZolpimistZolpidem2008-12-192025-2032
Sleep initiation and maintenance disorders
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
CAPROMAB PENDETIDE
prostatic neoplasms
,
carcinoma
Aglatimagene besadenovec
prostatic neoplasms
,
carcinoma
Enzastaurin
ehlers-danlos syndrome
,
syndrome
,
type iv ehlers-danlos syndrome
INDIUM IN 111 CAPROMAB PENDETIDE
prostatic neoplasms
,
carcinoma
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use